Inhibitors of leukotriene A4 hydrolase
US10399986B2 · kind B2 · utility
0Cited by
0References
21Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 14, 2017 |
| Grant date | Sep 3, 2019 |
| Priority date | — |
| Expiry date | Sep 14, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds encompassed by the Formula (I): pharmaceutical compositions thereof, methods for inhibiting LTA-4 hydrolase, and methods for the treatment of a disease and disorder which is ameliorated by the inhibition of LTA4h activity. Non-limiting examples of such diseases and conditions include inflammatory and autoimmune diseases and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.